Free Access
Med Sci (Paris)
Volume 23, Number 1, Janvier 2007
Page(s) 81 - 87
Section M/S revues
Published online 15 January 2007
  1. Rajamannan NM, Gersh B, Bonow RO. Calcific aortic stenosis: from bench to the bedside-emerging clinical and cellular concepts. Heart 2003; 89 : 801–5. [Google Scholar]
  2. Freeman RV, Otto CM. Spectrum of calcific aortic valve disease: pathogenesis, disease progression, and treatment strategies. Circulation 2005; 111 : 3316–26. [Google Scholar]
  3. Otto CM, O’Brien KD. Why is there discordance between calcific aortic stenosis and coronary artery disease ? Heart 2001; 85 : 601–2. [Google Scholar]
  4. Chan KL. Is aortic stenosis a preventable disease ? J Am Coll Cardiol 2003; 42 : 593–9. [Google Scholar]
  5. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 2005; 365 : 1415–28. [Google Scholar]
  6. Junquero D, Rival Y. Syndrome métabolique : quelle définition pour quels traitements ? Med Sci (Paris) 2005; 21 : 1045–53. [Google Scholar]
  7. Drolet MC, Roussel E, Deshaies Y, et al. A high fat/high carbohydrate diet induces aortic valve disease in C57BL/6J mice. J Am Coll Cardiol 2006; 47 : 850–5. [Google Scholar]
  8. Briand M, Lemieux I, Dumesnil JG, et al. Metabolic syndrome negatively influences disease progression and prognosis in aortic stenosis. J Am Coll Cardiol 2006; 47 : 2229–37. [Google Scholar]
  9. Després JP. Inflammation and cardiovascular disease: is abdominal obesity the missing link ? Int J Obes Relat Metab Disord 2003; 27 (suppl 3) : S22–4. [Google Scholar]
  10. Lihn AS, Pedersen SB, Richelsen B. Adiponectin: action, regulation and association to insulin sensitivity. Obes Rev 2005; 6 : 13–21. [Google Scholar]
  11. Briand M, Pibarot P, Despres JP, et al. Metabolic syndrome is associated with faster degeneration of bioprosthetic valves. Circulation 2006; 114 (suppl 1) : I512–7. [Google Scholar]
  12. Bellamy MF, Pellikka PA, Klarich KW, et al. Association of cholesterol levels, hydroxymethylglutaryl coenzyme-a reductase inhibitor treatment, and progression of aortic stenosis in the community. J Am Coll Cardiol 2002; 40 : 1723–30. [Google Scholar]
  13. Rosenhek R, Rader F, Loho N, et al. Statins but not angiotensin-converting enzyme inhibitors delay progression of aortic stenosis. Circulation 2004; 110 : 1291–5. [Google Scholar]
  14. Cowell SJ, Newby DE, Prescott RJ, et al. A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis. N Engl J Med 2005; 352 : 2389–97. [Google Scholar]
  15. Novaro GM, Sachar R, Pearce GL, et al. Association between apolipoprotein e alleles and calcific valvular heart disease. Circulation 2003; 108 : 1804–8. [Google Scholar]
  16. Ortlepp JR, Hoffmann R, Ohme F, et al. The vitamin D receptor genotype predisposes to the development of calcific aortic valve stenosis. Heart 2001; 85 : 635–8. [Google Scholar]
  17. Garg V, Muth AN, Ransom JF, et al. Mutations in Notch1 cause aortic valve disease. Nature 2005; 437 : 270–4. [Google Scholar]
  18. Cripe L, Andelfinger G, Martin LJ, et al. Bicuspid aortic valve is heritable. J Am Coll Cardiol 2004; 44 : 138–43. [Google Scholar]
  19. Bonow RO, Carabello BA, de Leon AC Jr, et al. Guidelines for the management of patients with valvular heart disease. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association task force on practice guide. Circulation 2006; 114 : 84–231. [Google Scholar]
  20. Garcia D, Pibarot P, Dumesnil JG, et al. Assessment of aortic valve stenosis severity: A new index based on the energy loss concept. Circulation 2000; 101 : 765–71. [Google Scholar]
  21. Briand M, Dumesnil JG, Kadem L, et al. Reduced systemic arterial compliance impacts significantly LV afterload and functions in aortic stenosis: implications for diagnosis and treatment. J Am Coll Cardiol 2005; 46 : 291–8. [Google Scholar]
  22. Garcia D, Dumesnil JG, Durand LG, et al. Discrepancies between catheter and Doppler estimates of valve effective orifice area can be predicted from the pressure recovery phenomenon: practical implications with regard to quantification of aortic stenosis severity. J Am Coll Cardiol 2003; 41 : 435–42. [Google Scholar]
  23. Kadem L, Dumesnil JG, Rieu R, et al. Impact of systemic hypertension on the assessment of aortic stenosis. Heart 2005; 91 : 354–61. [Google Scholar]
  24. Garcia D, Barenbrug PJ, Pibarot P, et al. A ventricular-vascular coupling model in presence of aortic stenosis. Am J Physiol Heart Circ Physiol 2005; 288 : 1874–84. [Google Scholar]
  25. Antonini-Canterin F, Huang G, Cervesato E, et al. Symptomatic aortic stenosis: does systemic hypertension play an additional role ? Hypertension 2003; 41 : 1268–72. [Google Scholar]
  26. Blais C, Pibarot P, Dumesnil JG, et al. Comparison of valve resistance with effective orifice area regarding flow dependence. Am J Cardiol 2001; 1 : 45–52. [Google Scholar]
  27. Blais C, Burwash IG, Mundigler G, et al. The projected valve area at normal flow rate improves the assessment of stenosis severity in patients with low flow aortic stenosis: the multicenter TOPAS (truly or pseudo severe aortic stenosis) study. Circulation 2006; 113 : 711–21. [Google Scholar]
  28. Monin JL, Quere JP, Monchi M, et al. Low-gradient aortic stenosis: operative risk stratification and predictors for long-term outcome: a multicenter study using dobutamine stress hemodynamics. Circulation 2003; 108 : 319–24. [Google Scholar]
  29. Pibarot P, Dumesnil JG. Prosthesis-patient mismatch: definition, clinical impact, and prevention. Heart 2005; 92 : 1022–9. [Google Scholar]
  30. Blais C, Dumesnil JG, Baillot R, et al. Impact of prosthesis-patient mismatch on short-term mortality after aortic valve replacement. Circulation 2003; 108 : 983–8. [Google Scholar]
  31. Tasca G, Mhagna Z, Perotti S, et al. Impact of prosthesis-patient mismatch on cardiac events and midterm mortality after aortic valve replacement in patients with pure aortic stenosis. Circulation 2006; 113 : 570–6. [Google Scholar]
  32. Andelfinger G. La valve aortique n’a pas révélé tous ses secrets. Med Sci (Paris) 2007; 23 : 93–4. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.